Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: Long-term results in 4 children

Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 6, 2003, Pages 788-794

  Milczuk, Henry A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ALPHA INTERFERON; CIDOFOVIR; ANTIVIRUS AGENT; CYTOSINE; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CASE REPORT; CHILD; CLINICAL TRIAL; DEBRIDEMENT; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LARYNX PAPILLOMATOSIS; MALE; MALIGNANT TRANSFORMATION; PROSPECTIVE STUDY; RECURRENT RESPIRATORY PAPILLOMATOSIS; SIDE EFFECT; INFANT; INTRALESIONAL DRUG ADMINISTRATION; LARYNX TUMOR; PAPILLOMA; PAPILLOMA VIRUS; PRESCHOOL CHILD; RECURRENT DISEASE; VIRUS INFECTION;

ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CYTOSINE; FEMALE; HUMANS; INFANT; INJECTIONS, INTRALESIONAL; LARYNGEAL NEOPLASMS; MALE; ORGANOPHOSPHORUS COMPOUNDS; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHOSPHONIC ACIDS; PROSPECTIVE STUDIES; RECURRENCE; TUMOR VIRUS INFECTIONS;

EID: 0038263954     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(03)00259-6     Document Type: Article

References (14)

1. Morgan AH, Zitsch RP. Recurrent respiratory papillomatosis in children: a retrospective study of management and complications. Ear Nose Throat J 1986;65:19-28.
2. Shikowitz MJ, Abramson AL, Freeman K, et al. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope 1998;108:962-7.
3. Rosen CA, Woodson GE, Thompson JW, et al. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 1998;118:810-5.
4. Leventhal BG, Kashima HK, Mounts P, et al. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. N Engl J Med 1991;325:613-7.
5. Healy GB, Gelber RD, Trowbridge AL, et al. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. N Engl J Med 1988;319:401-7.
6. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 1998;54:219-25.
7. Bielamowicz S, Villagomez V, Stager SV, et al. Intralesional cidofovir therapy for layrngeal papilloma in an adult cohort. Laryngoscope 2002;112:696-9.
8. Pransky SM, Brewster DF, Magit AE, et al. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000;126:1239-43.
9. Derkay CS, Malis DJ, Zalzal G, et al. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 1998;108:935-7.
10. Derkay CS. Recurrent respiratory papillomatosis. Laryngoscope 2001;111:57-69.
11. Sakakura A, Yamamoto Y, Takasaki T, et al. Recurrent laryngeal papillomatosis developing into laryngeal carcinoma with human papilloma virus (HPV) type 18: a case report. J Laryngol Otol 1996;110:75-7.
12. Koufman JA, Burke AJ. The etiology and pathogenesis of laryngeal carcinoma. Otolaryngol Clin North Am 1997;30:1-19.
13. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
14. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.